A DOUBLE-BLIND RANDOMIZED, PLACEBO-CONTROLLED, PHASE 2 STUDY EVALUATING THE SAFETY AND EFFICACY OF ORAL GKT137831 IN PATIENTS WITH TYPE 2 DIABETES AND ALBUMINURIA

UT Health San Antonio

The UT Health San Antonio, with missions of teaching, research and healing, is one of the country’s leading health sciences universities.

Principal Investigator(s)

Hura,Claudia E.

Funded by

GENKYOTEX

Research Start Date

01/01/2017

Status

Inactive

Clinical Care

Drug Discovery

Diabetes and Obesity

Bioscience Research Panel